MFMichael Fiegl

Michael Fiegl

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael Fiegl has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Christina Rieger

    Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany

    4 shared publications
  • Heidrun Drolle

    Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany

    4 shared publications
  • Michaela Wagner

    Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany

    4 shared publications
  • Silvia Sironi

    Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany

    4 shared publications
  • Christian Deniffel

    Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany

    3 shared publications
  • Alexander Kuett

    Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany

    2 shared publications

Latest Publications

  • Open Access

    Weight Loss and Decrease of Body Mass Index during Allogeneic Stem Cell Transplantation Are Common Events with Limited Clinical Impact

    by Christina T. Rieger, Isabel Wischumerski, Christian Rust, Michael Fiegl

    Weight loss in cancer patients has been attributed with significant morbidity and mortality. During allogeneic stem cell transplantation (SCT), oral nutrition is often hampered and hence total parenteral nutrition (TPN) is necessary. We therefore investigated the course of weight during stem cell transplantation and the clinical consequences of weight change. 180 consecutive patients who received allogeneic SCT between January 2010 and December 2011 at our center were analyzed for weight loss, laboratory and clinical parameters. During SCT, a median decrease of 6.6% of body mass index (BMI) was observed for the whole population (from 25.3 at admission to 23.6 at discharge), and a 1.6fold increase of malnutrition despite use of TPN (28.3% to 45.0%). 55.6% of patients experienced a significant weight loss of ≥5% with a median decrease of 9.2% in BMI. Serum levels of albumin, total protein and cholesterol rapidly decreased during conditioning therapy. After a median of 2.4 years, the median BMI was still only 23.4 (not different from discharge). However, we did not observe a meaningful difference in side effects and survival between patients that did or did not lose weight. Weight loss is commonly observed during allogeneic SCT despite TPN, but the clinical consequences thereof seem limited: we observed no significant impact on patients with a decrease ≥ 5% in BMI on transplant outcome, side effects or survival.


  • Open Access

    IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia

    by Alexander Kuett, Christina Rieger, Deborah Perathoner, Tobias Herold, Michaela Wagner, Silvia Sironi, Karl Sotlar, Hans-Peter Horny, Christian Deniffel, Heidrun Drolle, et al.

    The bone marrow microenvironment is physiologically hypoxic with areas being as low as 1% O2, e.g. the stem cell niche. Acute myeloid leukaemia (AML) blasts misuse these bone marrow niches for protection by the local microenvironment, but also might create their own microenvironment. Here we identify IL-8 as a hypoxia-regulated cytokine in both AML cell lines and primary AML samples that is induced within 48 hours of severe hypoxia (1% O2). IL-8 lacked effects on AML cells but induced migration in mesenchymal stromal cells (MSC), an integral part of the bone marrow. Accordingly, MSC were significantly increased in AML bone marrow as compared to healthy bone marrow. Interestingly, mononuclear cells obtained from healthy bone marrow displayed both significantly lower endogenous and hypoxia-induced production of IL-8. IL-8 mRNA expression in AML blasts from 533 patients differed between genetic subgroups with significantly lower expression of IL-8 in acute promyelocytic leukaemia (APL), while in non APL-AML patients with FLT ITD had the highest IL-8 expression. In this subgroup, high IL-8 expression was also prognostically unfavourable. In conclusion, hypoxia as encountered in the bone marrow specifically increases IL-8 expression of AML, which in turn impacts niche formation. High IL-8 expression might be correlated with poor prognosis in certain AML subsets.


  • Open Access

    Microenvironmental Hypoxia regulates FLT3 expression and biology in AML

    by Silvia Sironi, Michaela Wagner, Alexander Kuett, Heidrun Drolle, Harald Polzer, Karsten Spiekermann, Christina Rieger, Michael Fiegl

    Fms-like tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase constitutively expressed by acute myeloid leukaemia (AML) blasts. In addition, 25% of AML patients harbour a FLT3-ITD mutation, associated with inferior outcome due to increased relapse rate. Relapse might be propagated by interactions between AML blasts and the bone marrow microenvironment. Besides cellular elements of the microenvironment (e.g. mesenchymal stromal cells), bone marrow hypoxia has emerged as an additional crucial component. Hence, effects of hypoxia on FLT3 expression and biology could provide novel insight into AML biology. Here we show that 25% of AML patients down-regulate FLT3 expression on blasts in response to in vitro hypoxia (1% O2), which was independent of its mutational state. While virtually no AML cell lines regulate FLT3 in response to hypoxia, the down-regulation could be observed in Ba/F3 cells stably transfected with different FLT3 mutants. Hypoxia-mediated down-regulation was specific for FLT3, reversible and proteasome-dependent; with FLT3 half-life being significantly shorter at hypoxia. Also, PI-3K inhibition could partially abrogate down-regulation of FLT3. Hypoxia-mediated down-regulation of FLT3 conferred resistance against cytarabine in vitro. In conclusion, FLT3 expression in AML is dependent on the oxygen partial pressure, but response to hypoxia differs.


  • Hypoxia regulates proliferation of acute myeloid leukemia and sensitivity against chemotherapy

    by Heidrun Drolle, Michaela Wagner, Jochen Vasold, Alexander Kütt, Christian Deniffel, Karl Sotlar, Silvia Sironi, Tobias Herold, Christina Rieger, Michael Fiegl


  • The bone marrow microenvironment is a critical player in the NK cell response against acute myeloid leukaemia in vitro

    by Jochen Vasold, Michaela Wagner, Heidrun Drolle, Christian Deniffel, Alexander Kütt, Robert Oostendorp, Silvia Sironi, Christina Rieger, Michael Fiegl